What Are the Main Issues With Using Telemedicine for Risk Assessment for Monitoring of PAH Patients?
How Do We Define an Underserved PAH Patient?
If Telemedicine for the Routine Assessment of PAH Patients Is the “New Deal”, Are We Getting the Most Out of It?
Underserved PAH Populations: Why Don’t We Connect?
How Do Patients React to Telemedicine?
Clinical Reflections®: Reflecting on Missed Opportunities in Nontuberculous Mycobacteria Lung Disease